EAACI Congress 2025 Back
Sophia Karagiannis
United Kingdom
B cell immunologist with academic and biotechnology experience, focused on developing antibodies and antibody-drug conjugates for cancer therapy and dissecting humoral immunity in tumours. First to design and translate IgE therapies for cancer to clinical testing and founder of Epsilogen Ltd.
Sessions
Sunday 15 Jun
